Detalhe da pesquisa
1.
Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations.
Blood
; 139(12): 1850-1862, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34695176
2.
Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission.
Am J Hematol
; 99(5): 806-815, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38314662
3.
Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
Jpn J Clin Oncol
; 54(2): 153-159, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37986553
4.
Venetoclax plus low-dose cytarabine in patients with newly diagnosed acute myeloid leukemia ineligible for intensive chemotherapy: an expanded access study in Japan.
Jpn J Clin Oncol
; 53(7): 595-603, 2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37017320
5.
Venetoclax plus low-dose cytarabine in Japanese patients with untreated acute myeloid leukaemia ineligible for intensive chemotherapy.
Jpn J Clin Oncol
; 51(9): 1372-1382, 2021 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34322703
6.
Successful bridge therapy of gilteritinib to cord blood transplantation in relapsed acute myeloid leukemia after bone marrow transplantation.
J Infect Chemother
; 27(4): 639-641, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33214069
7.
Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia.
Ann Hematol
; 99(12): 2787-2800, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32879992
8.
[Treatments for Philadelphia chromosome-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era].
Rinsho Ketsueki
; 61(9): 1227-1235, 2020.
Artigo
em Japonês
| MEDLINE | ID: mdl-33162520
9.
[Outcomes of primary central nervous system lymphoma patients treated with high-dose methotrexate and rituximab].
Rinsho Ketsueki
; 60(2): 87-92, 2019.
Artigo
em Japonês
| MEDLINE | ID: mdl-30842385
10.
[â ¡. Advances in the Treatment of Adult Ph-Positive Acute Lymphoblastic Leukemia].
Gan To Kagaku Ryoho
; 51(5): 516-519, 2024 May.
Artigo
em Japonês
| MEDLINE | ID: mdl-38881060
11.
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL.
Ann Hematol
; 97(9): 1535-1545, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29694642
12.
[A novel quantitative JAK2V617F detection kit: prospective clinical performance study comparing MPN patients and healthy subjects].
Rinsho Ketsueki
; 59(6): 669-674, 2018.
Artigo
em Japonês
| MEDLINE | ID: mdl-29973441
13.
Phase II study of imatinib-based chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia.
Am J Hematol
; 92(4): 367-374, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28103625
14.
Myelodysplastic syndrome with myelofibrosis in which azacitidine therapy was effective and cord blood transplantation was carried out.
Rinsho Ketsueki
; 58(6): 601-606, 2017.
Artigo
em Japonês
| MEDLINE | ID: mdl-28679989
15.
[Human herpesvirus 8-negative primary effusion lymphoma-like lymphoma with t(8;14)(q24;q32)].
Rinsho Ketsueki
; 56(8): 1082-8, 2015 Aug.
Artigo
em Japonês
| MEDLINE | ID: mdl-26345571
16.
The demarcation between younger and older acute myeloid leukemia patients: a pooled analysis of 3 prospective studies.
Cancer
; 119(18): 3326-33, 2013 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23798329
17.
Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial.
Int J Hematol
; 116(2): 228-238, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35508695
18.
Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Blood Adv
; 6(2): 624-636, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516628
19.
Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML): Japan Adult Leukemia Study Group (JALSG)-AML206 study.
Cancer Sci
; 102(7): 1358-65, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21585619
20.
Administration schedule of daunorubicin for elderly patients with acute myelogenous leukemia: a single-institute experience.
Jpn J Clin Oncol
; 41(6): 820-4, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21415001